Показано 0 из 0
Дата |
---|
18.01.2023 |
17.01.2023 |
16.01.2023 |
13.01.2023 |
12.01.2023 |
11.01.2023 |
10.01.2023 |
09.01.2023 |
06.01.2023 |
05.01.2023 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
4.805
|
4.48
|
4.805
|
4.48
|
|
|
|
|
4.505
|
5.13
|
5.00
|
5.00
|
5.00
|
5.00
|
|
|
|
|
4.695
|
5.30
|
4.985
|
4.985
|
4.985
|
4.985
|
|
|
|
|
4.69
|
5.32
|
5.13
|
5.13
|
5.13
|
5.13
|
|
|
|
|
4.74
|
5.38
|
5.29
|
5.29
|
5.29
|
5.29
|
|
|
|
|
4.88
|
5.53
|
5.26
|
5.26
|
5.26
|
5.26
|
|
|
|
|
4.73
|
5.31
|
5.13
|
5.13
|
5.13
|
5.13
|
|
|
|
|
4.85
|
5.67
|
5.60
|
5.60
|
5.60
|
5.60
|
|
|
|
|
5.27
|
5.99
|
5.49
|
5.49
|
5.49
|
5.49
|
|
|
|
|
5.21
|
6.11
|
5.34
|
5.34
|
5.34
|
5.34
|
|
|
|
|
Kineta, Inc. is a clinical-stage bio-pharmaceutical company. The Company focuses on the discovery and development of adaptive immunity and T cell therapies for the treatments for neuro-degenerative diseases. Kineta operates in the United States.